0027
SHZ:002750
Kunming Longjin Pharmaceutical Co., Ltd.
- Stock
Last Close
2.08
25/09 07:04
Market Cap
624.78M
Beta: 0.49
Volume Today
8.60M
Avg: 8.96M
PE Ratio
−22.49
PFCF: −25.29
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 11.25M - | 14.12M 25.52% | 17.21M 21.95% | 20.65M 19.93% | 26.46M 28.17% | 28.53M 7.81% | 31.45M 10.25% | 45.19M 43.70% | 43.79M 3.11% | 30.34M 30.71% | |
average payables | 30.56M - | 34.86M 14.08% | 17.14M 50.83% | 7.26M 57.66% | 6.30M 13.22% | 10.88M 72.77% | 14.49M 33.12% | 14.63M 1.02% | 13.55M 7.40% | 10.96M 19.09% | |
average receivables | 19.80M - | 25.26M 27.55% | 27.80M 10.08% | 23.49M 15.52% | 35.80M 52.43% | 50.55M 41.19% | 42.93M 15.07% | 42.59M 0.80% | 52.32M 22.85% | 45.92M 12.23% | |
book value per share | 1.01 - | 0.95 5.44% | 1.60 67.73% | 1.67 4.85% | 1.61 3.70% | 1.61 0.18% | 1.56 3.48% | 1.59 1.91% | 1.59 0.15% | 1.46 8.51% | |
capex per share | -0.20 - | -0.06 68.99% | -0.06 3.53% | -0.06 7.74% | -0.04 25.53% | -0.04 11.54% | -0.02 54.41% | -0.06 233.84% | -0.03 56.30% | -0.06 144.38% | |
capex to depreciation | -15.66 - | -0.83 94.71% | -1.06 28.47% | -1.06 0.38% | -0.79 25.03% | -0.68 14.25% | -0.27 60.38% | -0.84 209.35% | -0.34 59.82% | -0.85 152.25% | |
capex to operating cash flow | -0.56 - | -0.26 52.95% | -0.34 29.52% | -0.23 33.74% | -0.30 33.69% | -0.49 62.19% | -1.75 257.05% | 3.48 299.14% | 0.70 79.93% | 1.75 149.74% | |
capex to revenue | -0.33 - | -0.10 70.41% | -0.13 33.83% | -0.11 20.16% | -0.06 45.31% | -0.05 19.76% | -0.03 44.42% | -0.09 261.71% | -0.01 84.15% | -0.21 1,292.02% | |
cash per share | 0.29 - | 0.31 6.19% | 0.53 72.28% | 0.13 74.77% | 0.17 26.40% | 0.95 463.50% | 1.01 5.71% | 1.03 1.97% | 1.07 4.00% | 1.01 5.57% | |
days of inventory on hand | 92.42 - | 102.29 10.67% | 105.69 3.32% | 186.84 76.78% | 320.57 71.58% | 299.36 6.62% | 270.10 9.77% | 388.61 43.88% | 24.80 93.62% | 396.52 1,498.73% | |
days payables outstanding | 338.77 - | 161.63 52.29% | 50.42 68.81% | 47.13 6.51% | 72.79 54.43% | 164.98 126.66% | 105.80 35.87% | 108.60 2.64% | 8.91 91.79% | 144.21 1,518.02% | |
days sales outstanding | 46.39 - | 54.11 16.63% | 55.98 3.46% | 31.25 44.17% | 62.88 101.20% | 52.85 15.96% | 49.34 6.63% | 68.91 39.65% | 29.45 57.27% | 104.38 254.47% | |
debt to assets | 0.07 - | 0.00 99.27% | 0.00 31.00% | 0.00 - | 0.00 3.03% | ||||||
debt to equity | 0.11 - | 0.00 99.45% | 0.00 32.94% | 0.00 - | 0.00 3.98% | ||||||
dividend yield | 0.04 - | 0.06 35.58% | 0.01 88.35% | 0.00 55.89% | 0.02 416.43% | 0.01 66.04% | 0.00 - | ||||
earnings yield | 0.05 - | 0.05 15.30% | 0.01 81.77% | 0.01 64.01% | 0.01 33.51% | 0.01 33.01% | -0.00 175.17% | 0.00 149.76% | -0.00 149.81% | -0.02 1,332.65% | |
enterprise value | 1.28B - | 1.31B 1.92% | 7.11B 443.35% | 6.51B 8.45% | 3.74B 42.51% | 1.86B 50.26% | 4.96B 166.51% | 3.23B 34.84% | 6.38B 97.42% | 4.27B 33.09% | |
enterprise value over ebitda | 14.27 - | 13.17 7.68% | 73.97 461.52% | 52.17 29.47% | 60.83 16.61% | 69.71 14.59% | 80.90 16.05% | 85.87 6.15% | 168.90 96.69% | -511.21 402.67% | |
ev to operating cash flow | 12.05 - | 18.64 54.65% | 101.26 443.18% | 62.42 38.36% | 64.44 3.23% | 58.70 8.91% | 1.23K 1,989.42% | -476.81 138.88% | -430.92 9.63% | -295.52 31.42% | |
ev to sales | 7.18 - | 6.98 2.73% | 39.17 461.24% | 29.10 25.72% | 12.29 57.77% | 5.54 54.93% | 18.01 225.27% | 12.72 29.38% | 9.08 28.61% | 34.71 282.24% | |
free cash flow per share | 0.16 - | 0.17 10.24% | 0.12 28.50% | 0.20 63.54% | 0.10 49.77% | 0.04 60.14% | -0.01 118.76% | -0.08 902.96% | -0.06 17.49% | -0.10 58.15% | |
free cash flow yield | 0.03 - | 0.04 10.24% | 0.01 83.22% | 0.01 94.23% | 0.01 13.55% | 0.01 32.25% | -0.00 108.16% | -0.01 1,440.34% | -0.00 57.14% | -0.01 129.19% | |
graham net net | -0.10 - | -0.10 5.89% | 0.35 461.74% | -0.02 107.01% | -0.04 81.66% | 0.75 1,803.18% | 0.77 2.67% | 0.84 9.53% | 0.84 0.14% | 0.75 10.72% | |
graham number | 2.38 - | 2.13 10.51% | 2.43 14.14% | 2.93 20.33% | 1.78 39.01% | 1.12 37.17% | 1.45 29.13% | 0.83 42.54% | 0.82 2.01% | 2.45 200.74% | |
income quality | 1.42 - | 1.10 22.19% | 1.14 2.96% | 1.15 0.80% | 1.65 44.16% | 2.29 38.83% | -0.17 107.37% | -0.87 417.40% | 1.98 327.06% | 0.20 90.10% | |
intangibles to total assets | 0.05 - | 0.05 0.96% | 0.03 39.03% | 0.02 10.45% | 0.02 5.90% | 0.04 68.29% | 0.06 64.13% | 0.06 10.42% | 0.06 2.43% | 0.06 1.50% | |
interest coverage | 420.63 - | 52.35 87.55% | 150.99 188.44% | 45.86 - | 1.62 96.46% | 14.79 - | -2.59 117.54% | ||||
interest debt per share | 0.00 - | 0.11 15,461.95% | 0.00 98.03% | 0.00 68.22% | 0.00 242.77% | 0.03 1,027.56% | 0.00 - | 0.04 704.49% | |||
inventory turnover | 3.95 - | 3.57 9.64% | 3.45 3.22% | 1.95 43.43% | 1.14 41.72% | 1.22 7.09% | 1.35 10.83% | 0.94 30.50% | 14.72 1,466.87% | 0.92 93.75% | |
invested capital | 0.11 - | 0.00 99.45% | 0.00 32.94% | 0.00 - | 0.00 3.98% | ||||||
market cap | 1.37B - | 1.37B 0.00% | 7.31B 433.12% | 6.56B 10.18% | 3.81B 41.91% | 2.24B 41.11% | 5.15B 129.60% | 3.36B 34.90% | 6.48B 93.13% | 4.46B 31.20% | |
net current asset value | -18.08M - | -13.52M 25.21% | 317.14M 2,445.92% | 360.54M 13.69% | 338.98M 5.98% | 340.95M 0.58% | 338.48M 0.73% | 382.56M 13.02% | 373.78M 2.30% | 328.60M 12.09% | |
net debt to ebitda | -0.97 - | -0.63 35.04% | -2.07 229.32% | -0.44 78.64% | -1.15 160.66% | -14.40 1,149.01% | -3.19 77.85% | -3.29 3.33% | -2.67 19.06% | 22.75 953.01% | |
net income per share | 0.25 - | 0.21 15.30% | 0.16 22.32% | 0.23 38.09% | 0.09 61.37% | 0.03 60.59% | -0.06 272.75% | 0.02 132.40% | -0.02 195.88% | -0.18 888.56% | |
operating cash flow per share | 0.35 - | 0.23 34.10% | 0.19 20.07% | 0.26 39.23% | 0.14 44.30% | 0.08 45.46% | 0.01 87.23% | -0.02 267.64% | -0.04 117.72% | -0.04 2.15% | |
payables turnover | 1.08 - | 2.26 109.60% | 7.24 220.60% | 7.74 6.96% | 5.01 35.25% | 2.21 55.88% | 3.45 55.94% | 3.36 2.58% | 40.95 1,118.40% | 2.53 93.82% | |
receivables turnover | 7.87 - | 6.75 14.26% | 6.52 3.34% | 11.68 79.11% | 5.80 50.30% | 6.91 19.00% | 7.40 7.10% | 5.30 28.39% | 12.40 134.02% | 3.50 71.79% | |
research and ddevelopement to revenue | 0.05 - | 0.05 10.73% | 0.05 4.09% | 0.09 79.35% | 0.09 5.21% | 0.10 7.58% | 0.08 21.84% | 0.08 2.69% | 0.03 63.86% | 0.20 627.74% | |
return on tangible assets | 0.18 - | 0.15 13.98% | 0.09 40.52% | 0.12 35.11% | 0.05 62.69% | 0.02 60.01% | -0.03 272.99% | 0.01 130.83% | -0.01 198.04% | -0.10 992.27% | |
revenue per share | 0.60 - | 0.62 4.78% | 0.48 22.64% | 0.56 15.55% | 0.76 36.16% | 0.84 10.24% | 0.69 17.98% | 0.63 7.71% | 1.75 175.63% | 0.31 82.44% | |
roe | 0.25 - | 0.22 10.43% | 0.10 53.69% | 0.14 31.70% | 0.05 59.89% | 0.02 60.66% | -0.04 278.98% | 0.01 131.79% | -0.01 195.74% | -0.13 980.48% | |
roic | 0.24 - | 0.20 18.14% | 0.09 52.82% | 0.13 40.37% | 0.06 56.80% | 0.02 59.24% | 0.06 164.30% | 0.01 76.03% | 0.01 0.55% | -0.06 531.55% | |
sales general and administrative to revenue | 0.05 - | 0.05 11.49% | 0.06 38.12% | 0.05 22.97% | 0.03 31.95% | 0.03 20.89% | 0.03 19.16% | 0.03 20.48% | 0.01 53.44% | 0.07 521.70% | |
shareholders equity per share | 1.01 - | 0.95 5.44% | 1.60 67.73% | 1.67 4.85% | 1.61 3.70% | 1.61 0.18% | 1.56 3.48% | 1.59 1.91% | 1.59 0.15% | 1.46 8.51% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 281.64M - | 265.72M 5.65% | 579.99M 118.27% | 651.56M 12.34% | 627.16M 3.74% | 624.91M 0.36% | 613.72M 1.79% | 655.95M 6.88% | 629.21M 4.08% | 559.77M 11.04% | |
tangible book value per share | 0.94 - | 0.89 5.65% | 1.54 74.41% | 1.63 5.31% | 1.57 3.73% | 1.56 0.46% | 1.53 1.69% | 1.64 6.90% | 1.57 4.40% | 1.40 10.77% | |
working capital | 3.44M - | 11.42M 232.16% | 346.54M 2,933.82% | 388.23M 12.03% | 366.79M 5.52% | 373.13M 1.73% | 374.23M 0.29% | 419.33M 12.05% | 409.37M 2.37% | 383.38M 6.35% |
All numbers in CNY (except ratios and percentages)